Regulation between O-GlcNAcylation and phosphorylation of neurofilament-M and their dysregulation in Alzheimer disease

FASEB Journal

Volumn 22, Issue 1, 2008, Pages 138-145

  Deng, Yanqiu ^a,c   Li, Bin ^a   Liu, Fei ^a   Iqbal, Khalid ^a   Grundke Iqbal, Inge ^a   Brandt, Roland ^b   Gong, Cheng Xin ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b UNIVERSITY OF OSNABRÜCK   (Germany)

^c TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Cytoskeleton; Glucose metabolism; Glycosylation

Indexed keywords

NEUROFILAMENT M PROTEIN; GLUCOSAMINE; GLUCOSE; NEUROFILAMENT PROTEIN;

ACYLATION; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; HUMAN TISSUE; MALE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; ANIMAL; BRAIN; IN VITRO STUDY; METABOLISM; PHOSPHORYLATION; TUMOR CELL LINE;

ANIMALIA; RATTUS;

ACYLATION; ALZHEIMER DISEASE; ANIMALS; BRAIN; CELL LINE, TUMOR; FEMALE; GLUCOSAMINE; GLUCOSE; HUMANS; MALE; NEUROFILAMENT PROTEINS; PHOSPHORYLATION; RATS;

EID: 38049121347     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.07-8309com     Document Type: Article

References (49)

1. Liu, Q., Xie, F., Siedlak, S. L., Nunomura, A., Honda, K., Moreira, P. I., Zhua, X., Smith, M. A., and Perry, G. (2004) Neurofilament proteins in neurodegenerative diseases. Cell. Mol. Life. Sci. 61, 3057-3075
2. Elder, G.A., Friedrich, V.L. Jr., Bosco, P., Kang, C., Gourov, A., Tu, P. H., Lee, V. M., and Lazzarini, R. A. (1998) Absence of the mid-sized neurofilament subunit decreases axonal calibers, levels of light neurofilament (NF-L), and neurofilament content. J. Cell Biol. l141, 727-739
3. Elder, G. A., Friedrich, V. L. Jr., Pereira, D., Tu, P. H., Zhang, B., Lee, V. M., and Lazzarini, R. A. (1999) Mice with disrupted midsized and heavy neurofilament genes lack axonal neurofilaments but have unaltered numbers of axonal microtubules. J. Neurosci. Res. 57, 23-32
4. Garcia, M. L., Lobsiger, C. S., Shah, S. B., Deerinck, T. J., Crum, J., Young, D., Ward, C. M., Crawford, T. O., Gotow, T., Uchiyama, Y., et al. (2003) NF-M is an essential target for the myelin-directed "outside- in" signaling cascade that mediates radial axonal growth. J. Cell Biol. 163, 1011-1020
5. Dong, D. L., Xu, Z. S., Chevrier, M. R., Cotter, R. J., Cleveland, D. W., and Hart, G. W. (1993) Glycosylation of mammalian neurofilaments. Localization of multiple O-linked N-acetylglucosamine moieties on neurofilament polypeptides L and M. J. Biol. Chem. 268, 16679-16687
6. Ludemann, N., Clement, A., Hans, V. H., Leschik, J., Behl, C., and Brandt, R. (2005) O-glycosylation of the tail domain of neurofilament protein M in human neurons and in spinal cord tissue of a rat model of amyotrophic lateral sclerosis (ALS). J. Biol. Chem. 280, 31648-31658
7. Lee, V. M., Otvos, L., Carden, M. J., Hollosi, M., Dietzschold, B., and Lazzarini, R. A. (1988) Identification of the major multiphosphorylation site in mammalian Neurofilaments. Proc. Natl. Acad. Sci. U. S. A. 85, 1998-2002
8. Xu, Z. S., Liu, W. S., and Willard, M. B. (1992) Identification of six phosphorylation sites in the COOH-terminal tail region of the rat neurofilament protein M. J. Biol. Chem. 267, 4467-4471
9. Dong, D. L., Xu, Z. S., Hart, G. W., and Cleveland, D. W. (1996) Cytoplasmic O-GlcNAc modification of the head domain and the KSP repeat motif of the neurofilament protein neurofilament-H. J. Biol. Chem. 271, 20845-20852
10. Trimpin, S., Mixon, A. E., Stapels, M. D., Kim, M. Y., Spencer, P. S., and Deinzer, M. L. (2004) Identification of endogenous phosphorylation sites of bovine medium and low molecular weight neurofilament proteins by tandem mass spectrometry. Biochemistry 43, 2091-2105
11. Petzold, A. (2005) Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration, and loss. J. Neurol. Sci. 233, 183-198
12. Kamemura, K., and Hart, G. W. (2003) Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: a new paradigm for metabolic control of signal transduction and transcription. Prog. Nucleic Acids Res. Mol. Biol. 73, 107-136
13. Sternberger, N. H., Sternberger, L. A., and Ulrich, J. (1985) Aberrant neurofilament phosphorylation in Alzheimer disease. Proc. Proc. Natl. Acad. Sci. U. S. A. 82, 4274-4276
14. Wang, J., Tung, Y. C., Wang, Y., Li, X. T., Iqbal, K., and Grundke-Iqbal, I. (2001) Hyperphosphorylation and accumulation of neurofilament proteins in Alzheimer disease brain and in okadaic acid-treated SY5Y cells. FEBS Lett. 507, 81-87
15. Perry, G., Rizzuto, N., Autilio-Gambetti, L., and Gambetti, P. (1985) Paired helical filaments from Alzheimer disease patients contain cytoskeletal components. Proc. Natl. Acad. Sci. U. S. A. 82, 3916-3920
16. Lee, V. M., Otvos, L. Jr., Schmidt, M. L., and Trojanowski, J. Q. (1988) Alzheimer disease tangles share immunological similarities with multiphosphorylation repeats in the two large neurofilament proteins. Proc. Natl. Acad. Sci. U. S. A. 85, 7384-7388
17. Gong, C.-X., Liu, F., Grundke-Iqbal, I., and Iqbal, K. (2006) Impaired brain glucose metabolism leads to Alzheimer neurofibrillary degeneration through a decrease in tau O-GlcNAcylation. J. Alzheimers Dis. 9, 1-12
18. Liu, F., Iqbal, K., Grundke-Iqbal, I., Hart, G. W., and Gong, C.-X. (2004) O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 101, 10804-10809
19. Li, X., Lu, F., Wang, J. Z., and Gong, C. X. (2006) Concurrent alterations of O-GlcNAcylation and phosphorylation of tau in mouse brains during fasting. Eur. J. Neurosci. 23, 2078-2086
20. Hoyer, S. (2000) Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: an update. Exp. Gerontol. 35, 1363-1372
21. Bensadoun, A., and Weinstein, D. (1976) Assay of proteins in the presence of interfering materials. Anal. Biochem. 70, 241-250
22. Gong, C.-X., Lidsky, T., Wegiel, J., Grundke-Iqbal, I., and Iqbal, K. (2001) Metabolically active rat brain slices as a model to study the regulation of protein phosphorylation in mammalian brain. Brain. Res. Brain. Res. Protoc. 6, 134-140
23. Fujiki, H., and Suganuma, M. (1993) Tumor promotion by inhibitors of protein phosphatases 1 and 2A: the okadaic acid class of compounds. Adv. Cancer Res. 61, 143-194
24. Sternberger, L. A., and Sternberger, N. H. (1983) Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. Proc. Natl. Acad. Sci. U. S. A. 80, 6126-6130
25. Lichtenberg-Kraag, B., Mandelkow, E. M., Biernat, J., Steiner, B., Schroter, C., Gustke, N., Meyer, H. E., and Mandelkow, E. (1992) Phosphorylation-dependent epitopes of neurofilament antibodies on tau protein and relationship with Alzheimer tau. Proc. Natl. Acad. Sci. U. S. A. 89, 5384-5388
26. Haltiwanger, R. S., Grove, K., and Philipsberg, G. A. (1998) Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAcbeta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate. J. Biol. Chem. 273, 3611-3617
27. Roos, M. D., Xie, W., Su, K., Clark, J. A., Yang, X., Chin, E., Paterson, A. J., and Kudlow, J. E. (1998) Streptozotocin, an analog of N-acetylglucosamine, blocks the removal of O-GlcNAc from intracellular proteins. Proc. Assoc. Am. Physicians 110, 422-432
28. Gong, C. X., Lidsky, T., Wegiel, J., Zuck, L., Grundke-Iqbal, I., and Iqbal, K. (2000) Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease. J. Biol. Chem. 275, 5535-5344
29. de Waegh, S. M., Lee, V. M., and Brady, S. T. (1992) Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 68, 451-463
30. Li, B. S., Zhang, L., Gu, J., Amin, N. D., and Pant, H. C. (2000) Integrin alpha(1) beta(1)-mediated activation of cyclin-dependent kinase 5 activity is involved in neurite outgrowth and human neurofilament protein H Lys-Ser-Pro tail domain phosphorylation. J. Neurosci. 20, 6055-6062
31. Kesavapany, S., Li, B. S., and Pant, H. C. (2003) Cyclin-dependent kinase 5 in neurofilament function and regulation. Neurosignals 12, 252-264
32. Veeranna, Amin, N. D., Ahn, N. G., Jaffe, H., Winters, C. A., Grant, P., and Pant, H. C. (1998) Mitogen-activated protein kinases (Erk1,2) phosphorylate Lys-Ser-Pro (KSP) repeats in neurofilament proteins NF-H and NF-M. J. Neurosci. 18, 4008-4021
33. Li, B. S., Daniels, M. P., and Pant, H. C. (2001) Integrins stimulate phosphorylation of neurofilament NF-M subunit KSP repeats through activation of extracellular regulated-kinases (Erk1/Erk2) in cultured motoneurons and transfected NIH 3T3 cells. J. Neurochem. 76, 703-710
34. Veeranna, Shetty, K. T., Link, W. T., Jaffe, H., Wang, J., and Pant, H. C. (1995) Neuronal cyclin-dependent kinase-5 phosphorylation sites in neurofilament protein (NF-H) are dephosphorylated by protein phosphatase 2A. J. Neurochem. 64, 2681-2690
35. Gong, C.-X., Wang, J. Z., Iqbal, K., and Grundke-Iqbal, I. (2003) Inhibition of protein phosphatase 2A induces phosphorylation and accumulation of neurofilaments in metabolically active rat brain slices. Neurosci. Lett. 340, 107-110
36. Kelly, W. G., Dahmus, M. E., and Hart, G. W. (1993) RNA polymerase II is a glycoprotein. Modification of the COOH-terminal domain by O-GlcNAc. J. Biol. Chem. 268, 10416-10424
37. Chou, T. Y., Dang, C. V., and Hart, G. W. (1995) Glycosylation of the c-Myc transactivation domain (O-linked N-acetylglucosamine/nuclear glycosylation/protein-protein interaction/protooncogene). Proc. Natl. Acad. Sci. U. S. A. 92, 4417-4421
38. Comer, F. I., and Hart, G. W. (2000) O-Glycosylation of nuclear and cytosolic proteins: dynamic interplay between O-GlcNAc and O-phosphate. J. Biol. Chem. 275, 29179-29182
39. Goldstein, M. E., Sternberger, N. H., and Sternberger, L. A. (1987) Phosphorylation protects neurofilaments against proteolysis. J. Neuroimmunol. 14, 149-160
40. Sanchez, I., Hassinger, L., Sihag, R. K., Cleveland, D. W., Mohan, P., and Nixon, R. A. (2000) Local control of neurofilament accumulation during radial growth of myelinating axons in vivo. Selective role of site-specific phosphorylation. J. Cell Biol. 151, 1013-1024
41. Iqbal, K., Alonso, A. del, C., Chen, S., Chohan, M.O., El-Akkad, E., Gong, C.-X., Khatoon, S., Li, B., Liu, F., Rahman, A., et al. (2005) Tau pathology in Alzheimer disease and other tauopathies. Biochim. Biophys. Acta 1739, 198-210
42. Gong, C. X., Singh, T. J., Grundke-Iqbal, I., and Iqbal, K. (1993) Phosphoprotein phosphatase activities in Alzheimer disease brain. J. Neurochem. 61, 921-927
43. Gong, C.-X., Shaikh, S., Wang, J. Z., Zaidi, T., Grundke-Iqbal, I., and Iqbal, K. (1995) Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. J. Neurochem. 65, 732-738
44. Liu, F., Grundke-Iqbal, I., Iqbal, K., and Gong, C.-X. (2005) Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur. J. Neurosci. 22, 1942-1950
45. Hoyer, S. (2004) Causes and consequences of disturbances of cerebral glucose metabolism in sporadic Alzheimer disease: therapeutic implications. Adv. Exp. Med. Biol. 541, 135-152
46. Reiman, E. M., Caselli, R. J., Chen, K., Alexander, G. E., Bandy, D., and Frost, J. (2001) Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 98, 3334-3339
47. Alexander, G. E., Chen, K., Pietrini, P., Rapoport, S. I., and Reiman, E. M. (2002) Evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer's disease treatment studies. Am. J. Psych. 159, 738-745
48. McLean, W. G., Pekiner, C., Cullum, N. A., and Casson, I. F. (1992) Posttranslational modifications of nerve cytoskeletal proteins in experimental diabetes. Mol Neurobiol. Mol. Neurobiol. 6, 225-237
49. Schechter, R., Beju, D., and Miller, K. E. (2005) The effect of insulin deficiency on tau and neurofilament in the insulin knockout mouse. Biochem. Biophys. Res. Commun. 334, 979-986